ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1310

Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience

Marie Blettery1, Lauren Brunier2, JULIA MARY3, Katlyne Polomat4, Florence MOINET4, Christophe Deligny5, Serge ARFI6, Georges JEAN BAPTISTE7 and Michel De Bandt8, 1rheumatology, CHU Fort de France, Fort de France, Martinique, 2CHUM de Martinique,, Unit of rheumatology, CHUM, 97200 Fort de France, France, 3RHEUMATOLOGY, CHU Fort de France, 97261, Martinique, 4Rheumatology and Internal Medicine, Zobda Quitman Hospital, Fort de France, Martinique, 5Zobda Quitman Hospital, Rheumatology and Internal Medicine, Fort de France, Martinique, 6University Hospital, CHU Fort de France, Fort de France, Martinique, 7RHEUMATOLOGY, CHU MARTINIQUE, FWI, Fort-de-France, Martinique, 8Rheumatology department, CHU Fort de France, Fort de France, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Polyarthritis and viruses

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Infection-related Rheumatic Disease - Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  To describe “chronic chikungunya (CHIK)” manifestations seen during the Caribbean outbreak from December 2013 to January 2015.

Methods: We report our experience as the only Rheumatology Department on Martinique Island. Patients were examined by a senior rheumatologist, using a standard care-report form, and CHIK was diagnosed collectively. The median time from acute CHIK to the first rheumatology consultation was calculated; severity was evaluated based on clinical scales and the degree of joint destruction. Each patient’s therapeutic strategy was recorded.

Results: The median time between acute CHIK and the first rheumatology consultation for the 147 patients analyzed was 8 months. After reviewing each patient’s chart, 19 (12.9%) had been given epidemic-influenced CHIK diagnoses. For the remaining 128 patients, with compatible history and positive serology, 4 distinct rheumatologic patterns were observed: 47 (31.9%) had reactivation of painful chronic mechanical manifestations; 9 (6.1%) had fibromyalgia; 45 (30.6%) met the criteria of spondyloarthritis, known for all before the CHIKV infection, and suffered a flare; and 27 (18.3%), with no history of joint disease, developed de novo bilateral symmetric chronic inflammatory joint disease in response to CHIKV infection.

Conclusion: The term “chronic CHIK syndrome” covers multiple etiologies. Compliance with the French Society of Rheumatology recommendations, careful history-taking and serologic verification help avoid errors inherent to the epidemic context and assure early therapeutic intervention for these patients, who should be managed by rheumatologists as early as possible to avoid late treatment onset.


Disclosure: M. Blettery, None; L. Brunier, None; J. MARY, None; K. Polomat, None; F. MOINET, None; C. Deligny, None; S. ARFI, None; G. JEAN BAPTISTE, None; M. De Bandt, None.

To cite this abstract in AMA style:

Blettery M, Brunier L, MARY J, Polomat K, MOINET F, Deligny C, ARFI S, JEAN BAPTISTE G, De Bandt M. Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/management-of-chronic-post-chikungunya-rheumatic-disease-the-martinican-experience/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/management-of-chronic-post-chikungunya-rheumatic-disease-the-martinican-experience/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology